A multifaceted risk management program to improve the reporting rate of patient safety incidents in primary care: a cluster-randomised controlled trial by Marc Chaneliere, Karine Buchet-Poyau, Maud Keriel-Gascou, Muriel Rabilloud, Cyrille Colin, Carole Langlois-Jacques, Sandrine Touzet

Get full text

Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial by Karine Buchet-Poyau, Pauline Occelli, Sandrine Touzet, Carole Langlois-Jacques, Sophie Figon, Jean-Pierre Dubois, Antoine Duclos, Marc Chanelière, Cyrille Colin, Muriel Rabilloud, Maud Keriel-Gascou

Get full text

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia

Get full text

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia

Get full text